| Class / Patent application number | Description | Number of patent applications / Date published |
|---|
| 514197000 | 6-position substituent contains carbocyclic ring | 18 |
| 20080207583 | Process For Preparing Granulates Comprising Amoxicillin - A novel process for preparing a stable granulate, which comprises a mixture of amoxicillin trihydrate and amoxicillin sodium, by means of extrusion granulation of amoxicillin trihydrate with an aqueous solution of sodium hydroxide, sodium bicarbonate, sodium carbonate and mixture thereof or with an aqueous solution of sodium salt of (C | 08-28-2008 |
| 20080269187 | Methods for Treatment and Prevention of Otitis Media Using Chemical Penetration Enhancers to Facilitate Transmembrane Drug Delivery Into the Middle Ear - Methods for treating and preventing middle ear infections by transmembrane administration of medicament-containing transmembrane carrier compositions comprising a chemical penetration enhancer, such as propylene glycol. The compositions are applied to the ear so as to contact the outer surface of an intact tympanic membrane to deliver the medicament across the membrane and into the middle ear. The medicaments delivered according to the methods of the invention include antibiotic, anti-viral, anti-fungal and anti-inflammatory agents that are useful in treatment and/or prophylaxis of middle ear infections and their sequelae. | 10-30-2008 |
| 20080312204 | SOLUBLE FORMS OF AMOXICILLIN AND TREATMENT OF ANIMALS - A solid mixture or aqueous solution of amoxicillin antibacterial agent with a material that aids in its dissolution in water to render it ingestive and palatable. | 12-18-2008 |
| 20100035856 | Beta-LACTAM-CONTAINING FORMULATIONS WITH INCREASED STABILITY IN AQUEOUS SOLUTION - The invention relates to novel formulations for dissolution in water which contain a β-lactam antibiotic and urea and whose pH after dissolution of the formulation in water is in the range of from 4.5 to 8. The formulations are suitable in particular for the treatment of bacterial diseases in animals. | 02-11-2010 |
| 20100168074 | Freezable Unit Dosage Delivery System and Method of Preparation - A freezable unit dosage delivery system, method of preparation, a solid unit dosage, method of treating symptoms and conditions, and kit is disclosed. The freezable unit dosage delivery system includes a composition, preferably containing one or more medicinal ingredients, having a freezing point less than 5° C.; a storage container comprising one or more cavity, each configured to receive a unit dosage quantity of the composition; and a sealing sheet for sealing engagement with the storage container. Upon freezing, the unit dosage quantity solidifies into a solid unit dosage that may be administered one of orally, rectally or vaginally for the local or systemic treatment of symptoms and conditions in a human. | 07-01-2010 |
| 20120022038 | ANIMAL TREATMENT FORMULATION AND METHODS OF USE - The present invention relates to a formulation for administration to the teat canal of the mammary gland of an animal, the formulation including: a physical barrier material, characterised in that the formulation includes sufficient antibiotic in relation to physical barrier material such that the formulation is configured to disintegrate over a period of time after administration to the teat canal. | 01-26-2012 |
| 20120115835 | METHODS FOR TREATMENT OF BACTERIAL INFECTIONS - The peptidoglycan layer is a vital component of the bacterial cell wall, which comprises 4→3 and 3→3 transpeptide cross-linkages, the formation of which are catalyzed by D,D- and L,D-transpeptidases, respectively. Methods for the treatment of bacterial infections with agents that inhibit L,D-transpeptidases, either alone or in combination with D,D-transpeptidase inhibitors, are provided herein. Also provided are methods for the treatment of chronic stage tuberculosis with agents that inhibit enzyme with L,D-transpeptidase activity. | 05-10-2012 |
| 20120264726 | METHODS OF SENSITIZING DRUG RESISTANT MICROORGANISMS USING METHYLSULFONYLMETHANE (MSM) - Embodiments of the invention relate generally to formulations comprising methylsulfonylmethane (MSM) and one or more therapeutic agents, and uses of such formulations to treat, inhibit and/or sensitize infectious diseases. In several embodiments, such formulations are effective to treat, inhibit and/or sensitize drug-resistant bacterial microorganisms, for example, methicillin-resistant | 10-18-2012 |
| 20120322782 | VETERINARY COMPOSITIONS - The present invention relates to veterinary compositions in a form of an orally deliverable tablet, and more particularly to a controlled-release composition that provides sufficiently long duration to permit once daily administration. | 12-20-2012 |
| 20130131033 | PHARMACEUTICAL COMPOSITION FOR TREATMENT OF RESPIRATORY TRACT INFECTIONS - The present invention relates to a pharmaceutical composition comprising ciprofloxacin or salts of thereof and amoxycillin or salts of thereof and other pharmaceutical excipients. The present invention provides more reliable effect against all bacteria, including the most commonly causative | 05-23-2013 |
| 20130281424 | ANTI-BACTERIAL SIDEROPHORE-AMINOPENICILLIN CONJUGATES - An artificial tris-catecolate siderophore with a tripodal backbone and its conjugates with ampicillin and amoxicillin were synthesized. Both conjugates exhibited significantly enhanced in vitro antibacterial activities against Gram-negative species compared to the parent drugs, especially against | 10-24-2013 |
| 20150080361 | VETERINARY COMPOSITIONS - The present invention relates to veterinary compositions in a form of an orally deliverable tablet, and more particularly to a controlled-release composition that provides sufficiently long duration to permit once daily administration. | 03-19-2015 |
| 20160060219 | INDOLINE ALKALOID COMPOUNDS - The present invention relates to indoline alkaloid compounds. In particular, indoline alkaloid compounds of the invention have antibacterial activity and/or are capable of resensitizing the susceptibility of methicillin-resistant | 03-03-2016 |
| 20160193153 | TABLET COMPRISING CROSPOVIDONE | 07-07-2016 |
| 20180021319 | COMPOSITIONS AND METHODS FOR TREATING GASTROINTESTINAL INFECTIONS | 01-25-2018 |
| 514198000 | Ampicillin per se or salt thereof | 3 |
| 20090318403 | ANTIBIOTIC COMPOSITION - The present invention provides antimicrobial compositions comprising an antibiotic and a sensitizer that enhances the effectiveness or activity of the antibiotic, wherein the sensitizer is preferably a primary amine containing a long alkyl chain. Such compositions are particularly useful for the treatment of infections by drug resistant bacteria. | 12-24-2009 |
| 20110269731 | NANOPARTICLES OF BETA-LACTAM DERIVATIVES - The present invention relates to a complex made up of at least one beta-lactam molecule covalently bonded to at least one hydrocarbon radical including at least 18 carbon atoms and containing at least one unit of 2-methyl-buta-2-ene, to nanoparticles of said complexes, and to a method for preparing same, said complex and/or said nanoparticles optionally being in the form of a lyophilisate. The present invention also relates to a pharmaceutical composition including at least said complex and/or said nanoparticles. The invention finally relates to said complex and/or to said nanoparticles for the treatment and/or prevention of bacterial infections, in particular caused by strains that are sensitive to beta-lactams. | 11-03-2011 |
| 20120028949 | Rapidly Disintegrating Tablet - The present invention relates to rapidly disintegrating tablets intended to be used as orodispersible tablets or dispersible tablets. They are ingested either by dispersing directly in the mouth or in water. The tablets include silicified microsrystalline cellulose. They are especially suitable for antibiotics. These tablets are also suitable for use in pediatric patients in the age above 3 years. For pediatric patients under 3 years the same tablets can be used as dispersible tablets. Rapidly disintegrating tablets which contain amoxicillin and clavulanic acid are also described. | 02-02-2012 |
